Biomarkers and Genomic Testing in Prostate Cancer: Integration Into Clinical Practice
San Francisco, CA US
January 7, 2016
Faculty:
E. David Crawford, MD
Neal D. Shore, MD, FACS
Target Audience
This activity was developed for urologists.
Learning Objectives
At the conclusion of this activity, participants should be better able to:
- Review advances in biomarker development
- Examine the clinical validation of prostate cancer (PCa) biomarkers
- Examine the clinical utility of these biomarkers and how to integrate into practice
- Utilize a case-based approach to demonstrate the clinical utility of new biomarkers
San Francisco Marriott Marquis
780 Mission St
San Francisco, CA
94103
United States
Available Credit
- 1.00 AMA PRA Category 1 Credit(s)™
- 1.00 Attendance